Back to search
HPV Vaccine
Clinical trial pipeline · Data from ClinicalTrials.gov
See which HPV Vaccine trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which HPV Vaccine trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the U…
This is a phase 2, open-label study to assess the immunogenicity of the 9-valent human papillomavirus (HPV) recombinant vaccine (Gardasil9) in people born male…
An open-label, controlled, multi-site, interventional, 2-arm, Phase II/III trial of BNT113 in combination with pembrolizumab vs pembrolizumab monotherapy as fir…
This study evaluates whether different types of digital health communication can increase parents' intention to vaccinate their daughters against human papillom…
The primary goal of this phase I open label study is to determine the safety and tolerability of pNGVL4aCRTE6E7L2 DNA vaccine, as administered by intramuscular…
To support international market access and comply with World Health Organization Prequalification requirements, this lot-to-lot consistency trial is planned for…
Background: Recurrent respiratory papillomatosis (RRP) is a rare disease that causes wart-like growths called papillomas to grow in the airway, most often in t…
Young adults aged 18-26 engage in a number of behaviors that increase their risk of developing cancer later in life including sedentary lifestyles, unhealthy ea…